Nuveen LLC Buys New Holdings in Orthofix Medical Inc. $OFIX

Key Points

• Nuveen LLC invested approximately $1.45 million in Orthofix Medical Inc., acquiring 88,620 shares and representing about 0.23% of the company's total stock.
• Recent analyst ratings for Orthofix Medical show a mix of opinions, with one "Strong Buy" rating and a target price of $16.00, while analysts have an average target price of $21.50 for the stock.
• Orthofix Medical reported a loss of $0.36 per share for its latest quarter, significantly missing analyst expectations despite achieving revenues of $203.12 million.

Nuveen LLC acquired a new position in Orthofix Medical Inc. (NASDAQ:OFIX - Free Report) during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 88,620 shares of the medical device company's stock, valued at approximately $1,445,000. Nuveen LLC owned 0.23% of Orthofix Medical as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Engine Capital Management LP lifted its holdings in Orthofix Medical by 2.4% during the fourth quarter. Engine Capital Management LP now owns 3,450,744 shares of the medical device company's stock valued at $60,250,000 after purchasing an additional 82,079 shares in the last quarter. Vanguard Group Inc. lifted its holdings in Orthofix Medical by 2.6% during the first quarter. Vanguard Group Inc. now owns 2,181,313 shares of the medical device company's stock valued at $35,577,000 after purchasing an additional 54,528 shares in the last quarter. Juniper Investment Company LLC lifted its holdings in Orthofix Medical by 123.5% during the fourth quarter. Juniper Investment Company LLC now owns 1,937,249 shares of the medical device company's stock valued at $33,824,000 after purchasing an additional 1,070,656 shares in the last quarter. Boone Capital Management LLC lifted its holdings in Orthofix Medical by 13.6% during the fourth quarter. Boone Capital Management LLC now owns 1,057,313 shares of the medical device company's stock valued at $18,461,000 after purchasing an additional 126,806 shares in the last quarter. Finally, Soleus Capital Management L.P. lifted its holdings in Orthofix Medical by 13.1% during the fourth quarter. Soleus Capital Management L.P. now owns 686,374 shares of the medical device company's stock valued at $11,984,000 after purchasing an additional 79,441 shares in the last quarter. Institutional investors own 89.76% of the company's stock.

Insider Transactions at Orthofix Medical

In other news, insider Aviva Mcpherron sold 3,728 shares of Orthofix Medical stock in a transaction on Wednesday, June 18th. The stock was sold at an average price of $10.51, for a total transaction of $39,181.28. Following the completion of the sale, the insider directly owned 46,322 shares in the company, valued at approximately $486,844.22. This trade represents a 7.45% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 1.30% of the stock is currently owned by corporate insiders.

Orthofix Medical Price Performance

OFIX traded down $0.15 during trading on Friday, reaching $14.55. 263,659 shares of the company traded hands, compared to its average volume of 475,984. The firm has a fifty day simple moving average of $12.54 and a 200 day simple moving average of $13.38. Orthofix Medical Inc. has a 12-month low of $10.24 and a 12-month high of $20.73. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.50 and a current ratio of 2.67. The company has a market cap of $574.58 million, a P/E ratio of -4.59 and a beta of 0.86.

Orthofix Medical (NASDAQ:OFIX - Get Free Report) last announced its quarterly earnings results on Tuesday, August 5th. The medical device company reported ($0.36) earnings per share for the quarter, missing the consensus estimate of $0.04 by ($0.40). Orthofix Medical had a negative return on equity of 25.43% and a negative net margin of 15.29%.The business had revenue of $203.12 million during the quarter, compared to the consensus estimate of $196.89 million. Orthofix Medical has set its FY 2025 guidance at EPS. On average, equities analysts forecast that Orthofix Medical Inc. will post -2.81 EPS for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on OFIX shares. Wall Street Zen raised shares of Orthofix Medical from a "sell" rating to a "hold" rating in a report on Saturday, August 9th. JMP Securities reaffirmed a "market perform" rating on shares of Orthofix Medical in a report on Friday, June 6th. Finally, Barrington Research raised shares of Orthofix Medical to a "strong-buy" rating and set a $16.00 price objective for the company in a report on Monday, June 23rd. One investment analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Buy" and an average price target of $21.50.

Orthofix Medical Profile

Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.